Drug intelligence / Profile preview

MDC1 shRNA

Development stage
Preclinical
Lead developer
Indian Institute of Technology Gandhinagar
Modality
Viral-delivered RNAi → In Vivo RNAi → Gene Silencing → Gene Therapies, RNA Therapeutics → Nucleic Acid Therapeutics
01

Overview

MDC1 shRNA is a short hairpin RNA designed to silence the expression of the Mediator of DNA Damage Checkpoint 1 (MDC1) protein. MDC1 is a critical adaptor protein in the ataxia telangiectasia mutated (ATM) signaling pathway, responsible for the recruitment and retention of DNA repair factors at sites of double-strand breaks. In cervical cancer cells, high MDC1 expression is associated with resistance to chemotherapy and radiotherapy. By knocking down MDC1, this shRNA sensitizes cancer cells to genotoxic stress, leading to increased apoptosis and reduced DNA repair capacity. Research conducted at the Indian Institute of Technology-Gandhinagar has demonstrated that stable knockdown of MDC1 in cervical cancer cell lines (HeLa, SiHa, CasKi) significantly enhances the efficacy of DNA-damaging treatments.

Other names
shMDC1shMDC-1shMDC 1MDC1-targeting shRNAMDC-1-targeting shRNAMDC 1-targeting shRNA
02

Targets

MDC1

Beyond the preview

Go deeper on MDC1 shRNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MDC1 shRNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call